Pressure-related skin injury (PRSI), also known as pressure ulcers or pressure injuries, represents a significant concern in immobile older adults, contributing to increased morbidity, healthcare costs, and diminished quality of life. This review synthesizes current evidence, pathophysiological mechanisms, clinical features, diagnostic approaches, and management strategies, incorporating recent advances and guideline-based recommendations to inform best practices for healthcare professionals.
As populations age globally, immobility and frailty among older adults have heightened the prevalence and clinical impact of pressure-related skin injury (PRSI). These injuries, resulting from prolonged pressure, especially over bony prominences, are preventable yet continue to pose challenges in acute, subacute, and long-term care settings. The multifactorial etiology and complex clinical trajectory of PRSIs necessitate a clear understanding of their epidemiology, pathophysiology, and evidence-based management to optimize patient outcomes and resource utilization.
Recent epidemiological data indicate that PRSI affects up to 25% of older adults in hospitals and 22% in long-term care facilities. The incidence is notably higher among those with reduced mobility, cognitive impairment, and chronic comorbidities. Pressure injuries are associated with increased hospitalization, longer length of stay, and a 2- to 6-fold increase in mortality risk. The economic burden is substantial, with annual costs exceeding billions of dollars globally, primarily due to prolonged care, surgical interventions, and secondary infections such as sepsis and osteomyelitis.
Pressure injuries arise when external pressure exceeds capillary closing pressure (approximately 32 mmHg), leading to ischemia and tissue necrosis. Immobile older adults are particularly susceptible due to age-related changes: thinning of the dermis, reduced collagen synthesis, diminished blood flow, and impaired cellular repair mechanisms. Shear and friction exacerbate tissue deformation, while microclimate factors (e.g., moisture, temperature) further compromise skin integrity. Reperfusion injury and local inflammatory responses intensify tissue damage, leading to ulceration and, in severe cases, deep tissue involvement.
Multiple intrinsic and extrinsic risk factors predispose immobile older adults to PRSI. Major intrinsic factors include advanced age, malnutrition, dehydration, sensory impairment (especially neuropathy), comorbid conditions (e.g., diabetes, vascular disease), and cognitive decline. Extrinsic factors encompass immobility, incontinence, inappropriate support surfaces, prolonged surgery, and inadequate repositioning. Risk assessment tools such as the Braden, Norton, and Waterlow scales facilitate early identification, though clinical judgment remains paramount.
PRSI typically presents over pressure-prone sites such as the sacrum, heels, ischial tuberosities, and trochanters. Early manifestations include non-blanchable erythema (Stage 1), progressing to partial-thickness skin loss (Stage 2), full-thickness tissue loss (Stage 3), and exposure of muscle, bone, or supporting structures (Stage 4). Unstageable injuries involve slough or eschar obscuring the wound bed. Deep tissue injury, characterized by persistent non-blanchable deep red or purple discoloration, may herald rapid progression. Systemic signs such as fever, pain, and malodor suggest secondary infection or underlying osteomyelitis.
Diagnosis is primarily clinical, based on careful inspection and staging of the wound according to standardized criteria (e.g., National Pressure Injury Advisory Panel - NPIAP). Assessment should include documentation of ulcer size, depth, exudate, peri-wound skin, and the presence of undermining or tunneling. Adjunctive tools such as photographic wound mapping, pressure mapping, and high-frequency ultrasound may assist in complex cases. Laboratory evaluation is warranted for suspected infection, with tissue biopsy reserved for atypical, non-healing, or rapidly deteriorating wounds.
Effective management of PRSI is multidisciplinary, integrating wound care, pressure redistribution, nutrition, and infection control. Core interventions include regular repositioning (every 2 hours), use of specialized mattresses or cushions, and meticulous skin hygiene. Debridement of necrotic tissue, appropriate wound dressings (e.g., hydrocolloids, foams), and negative pressure wound therapy are tailored to wound characteristics. Systemic antibiotics are indicated for clinical infection; however, prophylactic use is discouraged. Nutritional optimization, particularly protein and micronutrient supplementation, enhances healing. Patient and caregiver education is crucial for sustained prevention and adherence to care protocols.
Recent innovations include advanced wound dressings impregnated with antimicrobial agents, growth factors, or stem cell derivatives. Electrical stimulation, photobiomodulation, and shockwave therapy have shown promise in refractory cases. Bioengineered skin substitutes and topical platelet-rich plasma are under investigation for accelerating tissue repair. Digital technologies, such as pressure sensors and remote monitoring apps, enable real-time risk assessment and early intervention. Despite these advances, robust comparative trials and cost-effectiveness analyses remain limited, highlighting the need for ongoing research.
Major guidelines from the NPIAP, European Pressure Ulcer Advisory Panel (EPUAP), and Pan Pacific Pressure Injury Alliance (PPPIA) emphasize comprehensive risk assessment, individualized prevention plans, and timely intervention. Recommendations include the use of validated risk tools, frequent repositioning, support surface optimization, adequate nutrition, and prompt management of moisture and incontinence. Interdisciplinary collaboration and regular staff training are essential for sustained improvement. Guideline adherence correlates with reduced incidence, faster healing, and lower complication rates.
Pressure-related skin injury in immobile older adults represents a complex, multifaceted clinical challenge with significant implications for patient morbidity, mortality, and healthcare resource use. A mechanistic understanding of pathophysiology, vigilant risk assessment, and adherence to guideline-driven prevention and management strategies are fundamental to optimizing outcomes. Ongoing research into novel therapies and technologies holds promise for further enhancing care quality and reducing the burden of this preventable condition among vulnerable older populations.
1.
New Nanoparticles Can Destroy Undruggable Cancer Proteins
2.
Brain MRI Surveillance Alone Helps Preserve Cognition in Small Cell Lung Cancer
3.
NEET SS Counseling 2023: MCC provides information on DNB SS Medical Oncology seats available at ESIC Medical College and Hospital Faridabad.
4.
Belzutifan Plus Pembro Approved for Adjuvant RCC
5.
Using MRD Status to Deescalate Multiple Myeloma Therapy
1.
Diagnosis and Treatment of Follicular Thyroid Cancer: A Comprehensive Guide
2.
Obesity as a major risk factor for cancer
3.
Unraveling the Genetic Mystery of Hereditary Spherocytosis
4.
Advanced Pathways in Oncology for Better Care
5.
Essential Updates in Hematology in Daily Practice
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
Understanding Anemia and Its Common Causes
4.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
5.
Early Cancer Detection Saves Lives
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation